Are high CSF levels of CXCL13 helpful for diagnosis of Lyme neuroborreliosis?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Neuroborreliosis (NB) is a serious complication of infection with the spirochete Borrelia burgdorferi that presents with a variety of clinical manifestations. Identification of Lyme NB and the decision to treat with IV or oral antibiotics are common challenges.1,2 For persons in endemic areas who present with classic manifestations of Lyme NB and evidence of systemic infection with B burgdorferi, the diagnosis is straightforward. However, for cases with atypical manifestations or ambiguous serology, diagnostic confirmation of Lyme NB can be difficult. The current method of choice for diagnosis of Lyme NB is the demonstration of CSF abnormalities (i.e., increased leukocyte count or elevated albumin CSF/serum ratio, indicating blood–CSF barrier dysfunction) plus the demonstration of intrathecal synthesis of Borrelia-specific antibodies.2,3 These tests suffer from important limitations. 1) Elevated CSF leukocytes or protein are not specific, and are found in other infectious and noninfectious inflammatory CNS diseases.3,4 2) Intrathecal production of Borrelia antibodies may be absent at the time of diagnostic lumbar puncture.4 3) Even the demonstration of intrathecal Borrelia-specific antibodies does not necessarily discriminate between active and past infection; specific antibody production persists for years in spite of successful treatment.5 In fact, an important problem is the difficulty determining whether …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
Alert Me
Recommended articles
-
ARTICLES
Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosisHayrettin Tumani, Georg Nolker, Hansotto Reiber et al.Neurology, September 01, 1995 -
Articles
A prospective study on the role of CXCL13 in Lyme neuroborreliosisC. Schmidt, A. Plate, B. Angele et al.Neurology, March 21, 2011 -
Editorials
Sublime diagnosis of Lyme neuroborreliosisBenjamin M. Segal, Eric L. Logigian et al.Neurology, August 08, 2005 -
Articles
Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patientsF. Blanc, B. Jaulhac, M. Fleury et al.Neurology, September 04, 2007